TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
IMUX

Immunic Inc

Healthcare · Biotechnology

8.10$ +1.4% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Balance Sheet

Immunic Inc (IMUX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 159 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet IMUX
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
72 64 91 81 70 60 47 35 20 15 10 73 68 66 57 87 172 168 155 136 157 139 150 139 121 128 109 89 67 54 104 86 65 41 21 61 41 24 190 159
69 61 88 78 68 58 45 33 19 14 10.0 39 35 32 24 53 138 134 120 102 122 105 116 105 87 126 107 87 65 53 103 85 63 39 19 60 39 23 189 158
68 60 87 76 66 57 44 31 18 13 9.6 36 30 29 19 49 133 127 115 87 110 87 96 88 73 107 93 77 60 47 97 80 59 36 14 55 35 15 187 155
68 60 87 76 66 57 44 31 18 13 9.6 36 30 29 19 49 133 127 115 87 110 87 96 88 73 116 97 77 60 47 97 80 59 36 14 55 35 15 187 155
– – – – – 0.3 – – – – – 0.9 – 0.8 0.2 0.3 0.2 0.3 0.3 4.1 0.3 0.3 0.6 0.4 0.2 0.3 0.8 1.2 1.2 0.7 1.4 1.5 0.8 0.7 0.6 0.6 0.2 4.1 0.4 –
– – – – – 0.0 – – – – – – – – 3.7 2.7 -1.1 3.4 2.6 6.6 7.9 -2.2 15 -3.3 8.9 5.6 -3.7 3.8 2.3 – – – – – – – – – – –
2.9 2.5 2.5 2.4 2.3 2.2 2.1 2.1 0.9 0.7 0.5 0.0 0.0 0.1 0.1 1.1 1.1 0.2 0.2 1.4 0.2 1.1 0.2 0.9 1.4 0.3 0.3 0.3 – – – – – – – – – – – –
– – – – – 0.0 – – – – – 33 33 33 33 33 33 33 33 33 33 33 33 33 33 0.0 – – – – – – – – – – – – – –
– – – – – 2.7 – – 3.0 – – – – – – – – – 33 – – – – – 33 – – – – – – – – – – – – – – –
4.7 5.6 6.5 7.3 8.3 10 9.7 8.3 5.7 2.6 1.4 3.2 7.1 7.6 6.8 8.5 8.8 9.1 17 15 11 12 12 11 12 14 18 19 19 25 21 23 24 22 26 28 30 31 39 32
4.6 5.5 6.5 7.3 8.2 10 9.7 8.3 5.7 2.5 1.4 3.1 7.0 7.1 6.3 7.7 8.0 8.4 16 14 11 11 11 10 12 13 16 18 18 25 20 23 23 22 26 27 30 31 38 31
– – – – – 0.0 – – – – 0.0 – – 3.3 4.0 5.5 – 0.3 0.4 0.2 0.4 0.4 0.4 0.4 0.4 0.6 0.6 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.8 0.8 0.7 0.5 0.3 0.2
1.2 0.8 1.3 1.1 1.0 1.0 0.9 1.1 1.1 0.3 0.2 1.5 3.7 2.4 1.4 1.7 3.4 3.7 10 4.2 3.2 3.7 3.3 4.1 4.2 4.3 5.2 4.7 3.2 5.1 6.2 7.6 5.8 7.8 5.5 7.9 7.3 10 11 13
– – – – – 0.0 – – – – 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
68 58 84 73 62 50 37 26 14 12 9.0 69 61 58 50 79 163 159 137 121 145 127 138 128 109 114 91 69 48 29 84 64 41 18 -5.3 34 10 -6.7 151 128
-232 -244 -256 -269 -281 -296 -310 -323 -335 -337 -347 -44 -52 -60 -68 -80 -93 -104 -138 -156 -176 -197 -218 -240 -261 -317 -343 -367 -389 -411 -440 -462 -486 -511 -537 -564 -589 -609 -641 -675
0.8 0.8 0.8 1.1 1.1 1.1 0.1 0.0 0.1 0.1 8.5 1.0 1.0 1.0 1.1 1.3 1.8 2.1 2.1 2.2 2.5 2.6 2.8 3.0 3.1 3.5 4.4 4.4 4.5 4.5 9.7 10 10 9.0 10 13 19 12 30 43

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?